ANI-7 structure 
             | 
        Common Name | ANI-7 | ||
|---|---|---|---|---|
| CAS Number | 931417-26-4 | Molecular Weight | 263.121 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C13H8Cl2N2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
            Use of ANI-7A potent and selective (up to 263-fold) inhibitor of breast cancer cells with GI50 of 0.5 uM (MCF-7), via activation the aryl hydrocarbon receptor (AhR) pathway; inhibits other cell lines derived from other tumour types with GI50 of 3.2-46 uM (lung, colon, ovary, neuronal, glial, prostate, and pancreas); potently inhibits the growth of T47D, ZR-75-1, MCF-7, SKBR3, and MDA-MB-468 breast cancer cells with GI50 of 0.16-0.38 uM, induces cell cycle arrest checkpoint activation and DNA damage; binds to the AhR, induces translocation to the nucleus, activates the XRE, induces CYP1 activity, culminating in cell cycle arrest, checkpoint activation, DNA damage and cell death.  | 
    
| Name | ANI-7 | 
|---|
| Description | A potent and selective (up to 263-fold) inhibitor of breast cancer cells with GI50 of 0.5 uM (MCF-7), via activation the aryl hydrocarbon receptor (AhR) pathway; inhibits other cell lines derived from other tumour types with GI50 of 3.2-46 uM (lung, colon, ovary, neuronal, glial, prostate, and pancreas); potently inhibits the growth of T47D, ZR-75-1, MCF-7, SKBR3, and MDA-MB-468 breast cancer cells with GI50 of 0.16-0.38 uM, induces cell cycle arrest checkpoint activation and DNA damage; binds to the AhR, induces translocation to the nucleus, activates the XRE, induces CYP1 activity, culminating in cell cycle arrest, checkpoint activation, DNA damage and cell death. | 
|---|---|
| References | References 1. Gilbert J, et al. Mol Pharmacol. 2017 Dec 21. pii: mol.117.109827. View Related Products by Target Aryl hydrocarbon Receptor (AhR) | 
| Molecular Formula | C13H8Cl2N2 | 
|---|---|
| Molecular Weight | 263.121 |